If overwhelming efficacy is demonstrated at an interim readout then the trial has to be halted and the placebo patients offered the treatment. Clearly immoral not to do so ... also a legal minefield if this was not done.
Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-216
-
- There are more pages in this discussion • 230 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.015(1.52%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.01 | 98.5¢ | $450.5K | 454.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 56430 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 50548 | 6 |
View Market Depth
| Last trade - 10.33am 15/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |